{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:13:56Z","timestamp":1794741236066,"version":"4.9.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1136\/annrheumdis-2011-201268","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T22:20:46Z","timestamp":1341008446000},"page":"678-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":359,"title":["Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review"],"prefix":"10.1016","volume":"72","author":[{"given":"Nienke","family":"ter Haar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Uziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kon\u00e9-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Insalaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman","family":"Al-Mayouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Gallizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efimia","family":"Papadopoulou-Alataki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Obici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Iagaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-201268_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/annrheumdis-2011-201268_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00431-011-1411-z","article-title":"The Eurofever Project: towards better care for autoinflammatory diseases.","volume":"170","author":"Ozen","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","author":"Toplak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib4","unstructured":"Oxford Centre for Evidence-based Medicine Levels of Evidence (March 2009) http:\/\/www.cebm.net\/index.aspx?o=1025. (accessed 19 Dec 2011)."},{"key":"10.1136\/annrheumdis-2011-201268_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-81-6-792","article-title":"Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study.","volume":"81","author":"Goldstein","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2011-201268_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM197410312911803","article-title":"A controlled trial of colchicine in preventing attacks of familial Mediterranean fever.","volume":"291","author":"Zemer","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2011-201268_bib7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial Mediterranean fever. A double-blind trial.","volume":"291","author":"Dinarello","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2011-201268_bib8","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement.","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"issue":"4 Suppl 50","key":"10.1136\/annrheumdis-2011-201268_bib9","first-page":"S49","article-title":"Non-response to colchicine in FMF: definition, causes and suggested solutions.","volume":"26","author":"Ben-Chetrit","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jbspin.2007.10.004","article-title":"Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion.","volume":"75","author":"Erken","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1136\/annrheumdis-2011-201268_bib11","first-page":"1708","article-title":"Protracted febrile myalgia in patients with familial Mediterranean fever.","volume":"21","author":"Langevitz","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/36.9.1005","article-title":"The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study.","volume":"36","author":"Tunca","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib13","first-page":"1362","article-title":"Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever.","volume":"35","author":"Tweezer-Zaks","year":"2008","journal-title":"J Rheumatol"},{"issue":"4 Suppl 34","key":"10.1136\/annrheumdis-2011-201268_bib14","first-page":"S41","article-title":"The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.","volume":"22","author":"Calguneri","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"4 Suppl 34","key":"10.1136\/annrheumdis-2011-201268_bib15","first-page":"S37","article-title":"The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial.","volume":"22","author":"Tunca","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"5 Suppl 42","key":"10.1136\/annrheumdis-2011-201268_bib16","first-page":"S99","article-title":"Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.","volume":"24","author":"Seyahi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.","volume":"38","author":"Ozen","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","article-title":"Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.","volume":"41","author":"Meinzer","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","article-title":"Effects of anti-tumor necrosis factor agents for familial Mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment.","volume":"17","author":"Bilgen","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib20","first-page":"i34","article-title":"Efficacy and safety of canakinumab (ACZ885), a fully human anti-interleukin-1beta antibody, in cryopyrinassociated periodic fever syndrome: results of a multicenter, randomized, double-blind, phase III study","volume":"48","author":"Lachmann","year":"2009","journal-title":"Rheumatology"},{"key":"10.1136\/annrheumdis-2011-201268_bib21","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes.","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib22","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1186\/ar3526","article-title":"NLRP3 E311K mutation in a large family with Muckle-Wells syndrome: description of a heterogeneous phenotype and response to treatment.","volume":"13","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-201268_bib23","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1186\/ar3266","article-title":"Canakinumab (ACZ885, a fully human IgG1 anti-IL-1\u03b2 mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).","volume":"13","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2011-201268_bib24","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib25","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib26","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","article-title":"Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.","volume":"364","author":"Hoffman","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2011-201268_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2011-201268_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2310\/7750.2008.07050","article-title":"Use of anakinra (Kineret) in the treatment of familial cold autoinflammatory syndrome with a 16-month follow-up.","volume":"12","author":"Ross","year":"2008","journal-title":"J Cutan Med Surg"},{"key":"10.1136\/annrheumdis-2011-201268_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.30149","article-title":"Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome","volume":"63","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archderm.142.12.1591","article-title":"Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1\/NALP3 mutations.","volume":"142","author":"Leslie","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jpeds.2010.02.040","article-title":"Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with anakinra.","volume":"157","author":"Lepore","year":"2010","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome.","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/art.34409","article-title":"Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease (NOMID) treated with anakinra.","author":"Sibley","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"Stojanov","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib35","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","article-title":"The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.","volume":"46","author":"Dod\u00e9","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keg070","volume":"42","author":"Drewe","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-201268_bib37","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/ard.2005.048611","article-title":"Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.","volume":"65","author":"Ravet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib38","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/ard.2010.143438","article-title":"Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.","volume":"70","author":"Obici","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib41","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2010.144279","article-title":"Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome.","volume":"70","author":"Quillinan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/annrheumdis-2011-201268_bib43","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/rheumatology\/kem231","article-title":"Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).","volume":"46","author":"Drewe","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-201268_bib44","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","article-title":"Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.","volume":"60","author":"Nedjai","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/annrheumdis-2011-201268_bib46","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients.","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"10.1136\/annrheumdis-2011-201268_bib47","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0022-3565(24)29496-9","article-title":"Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.","volume":"298","author":"Drenth","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1136\/annrheumdis-2011-201268_bib48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/annrheumdis-2011-201268_bib49","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency.","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-201268_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11926-010-0086-1","article-title":"Hyperimmunoglobulin D syndrome in childhood.","volume":"12","author":"van der Hilst","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/annrheumdis-2011-201268_bib51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/annrheumdis-2011-201268_bib52","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/rheumatology\/kei178","article-title":"Peculiarities of PAPA syndrome.","volume":"45","author":"Tallon","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-201268_bib53","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/art.34332","article-title":"Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).","volume":"64","author":"Demidowich","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib54","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2011-201268_bib55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.30170","article-title":"Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation.","volume":"63","author":"Borghini","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-201268_bib56","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.ijporl.2010.08.014","article-title":"PFAPA syndrome in children: a meta-analysis on surgical versus medical treatment.","volume":"74","author":"Peridis","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1136\/annrheumdis-2011-201268_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/000348940311200412","article-title":"Update on treatment of Marshall's syndrome (PFAPA syndrome): report of five cases with review of the literature.","volume":"112","author":"Berlucchi","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1136\/annrheumdis-2011-201268_bib58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/adc.2005.084731","article-title":"PFAPA syndrome: new clinical aspects disclosed.","volume":"91","author":"Tasher","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1136\/annrheumdis-2011-201268_bib59","first-page":"358","article-title":"Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults.","volume":"10","author":"Padeh","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"10.1136\/annrheumdis-2011-201268_bib60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1651-2227.2009.01554.x","article-title":"A clinical review of 105 patients with PFAPA (a periodic fever syndrome).","volume":"99","author":"Feder","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib61","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jpeds.2011.06.004","article-title":"Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome.","volume":"159","author":"Wurster","year":"2011","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib62","first-page":"269","article-title":"Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers.","volume":"30","author":"Cantarini","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2011-201268_bib63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3476(99)70335-5","article-title":"Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome.","volume":"135","author":"Padeh","year":"1999","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib64","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archoto.2009.56","article-title":"Outcome of tonsillectomy in selected patients with PFAPA syndrome.","volume":"135","author":"Pignataro","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1136\/annrheumdis-2011-201268_bib65","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1651-2227.2008.00837.x","article-title":"Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes.","volume":"97","author":"Tasher","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib66","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1073\/pnas.1103681108","article-title":"Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade.","volume":"108","author":"Stojanov","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/annrheumdis-2011-201268_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008669","article-title":"Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA).","volume":"9","author":"Burton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/annrheumdis-2011-201268_bib68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archoto.2007.7","article-title":"Effect of adenotonsillectomy in PFAPA syndrome.","volume":"134","author":"Licameli","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1136\/annrheumdis-2011-201268_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jpeds.2007.03.015","article-title":"A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome.","volume":"151","author":"Renko","year":"2007","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archoto.2007.15","article-title":"Role of Tonsillectomy in PFAPA syndrome.","volume":"134","author":"Wong","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1136\/annrheumdis-2011-201268_bib71","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjoto.2009.06.005","article-title":"Surgical outcomes and histology findings after tonsillectomy in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome.","volume":"31","author":"Peridis","year":"2010","journal-title":"Am J Otolaryngol"},{"key":"10.1136\/annrheumdis-2011-201268_bib72","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jpeds.2009.02.038","article-title":"Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study.","volume":"155","author":"Garavello","year":"2009","journal-title":"J Pediatr"},{"key":"10.1136\/annrheumdis-2011-201268_bib73","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","article-title":"Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.","volume":"107","author":"Simon","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724215259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724215259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-201268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:45:49Z","timestamp":1737333949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724215259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0003496724215259"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-201268","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-201268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 \u00a9 2013 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}